Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 11, 2015, Pages 14725-14732

  Li, Kai ^a   Zhu, Zhengpeng ^a   Luo, Jin ^a   Fang, Jingyi ^a   Zhou, Huanhuan ^a   Hu, Min ^b   Maskey, Ninu ^b   Yang, Guifang ^b  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Biomarker; CD4; CD8; CXCR3; Gastric cancer; Prognosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BIOMARKERS, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CXCR3; STOMACH NEOPLASMS;

EID: 85013374524     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917
2. Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull 2008; 85: 87-100
3. Chen R, He Q, Cui J, Bian S, Chen L. Lymph node metastasis in early gastric cancer. Chin Med J 2014; 127: 560-567
4. Ma Y, Adjemian S, Galluzzi L, Zitvogel L, Kroemer G. Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. Oncoimmunology 2014; 3: e27663
5. Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett 2008; 267: 226-244
6. Zhu Q, Han X, Peng J, Qin H, Wang Y. The role of CXC chemokines and their receptors in the progression and treatment of tumors. J Mol Histol 2012; 43: 699-713
7. Lee HJ, Song IC, Yun HJ, Jo DY, Kim S. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. WJG 2014; 20: 1681-1693
8. Amatschek S, Lucas R, Eger A, Pflueger M, Hundsberger H, Knoll C, Grosse-Kracht S, Schuett W, Koszik F, Maurer D and Wiesner C. CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. Br J Cancer 2011; 104: 469-479
9. Wu Z, Han X, Yan J, Pan Y, Gong J, Di J, Cheng Z, Jin Z, Wang Z, Zheng Q, Wang Y. The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma. Biomed Pharmacother 2012; 66: 373-377
10. Li L, Chen J, Lu ZH, Yu SN, Luo YF, Zhao WG, Ma YH, Jia CW. Significance of chemokine receptor CXCR3 expression in breast cancer. Zhonghua Bing Li Xue Za Zhi 2011; 40: 85-88
11. Klatte T, Seligson DB, Leppert JT, Riggs SB, Yu H, Zomorodian N, Kabbinavar FF, Strieter RM, Belldegrun AS and Pantuck AJ. The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol 2008; 179: 61-66
12. Nagpal ML, Davis J, Lin T. Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation. Biochim Biophys Acta 2006; 1762: 811-818
13. Ocana E, Delgado-Perez L, Campos-Caro A, Muñóz J, Paz A, Franco R, Brieva JA. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells. Haematologica 2007; 92: 349-356
14. Billottet C, Quemener C, Bikfalvi A. CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta 2013; 1836: 287-295
15. Verbeke H, Geboes K, Van Damme J, Struyf S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta 2012; 1825: 117-129
16. Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and so-called Intestina-type Carcinoma. An Attempt at a Histo-clinical Classification. Acta Pathol Microbiol Scand 1965; 64: 31-49
17. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010; 17: 3077-3079
18. Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 2010; 106: 91-111
19. Balkwill FR. The chemokine system and cancer. J Pathol 2012; 226: 148-157
20. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007; 98: 1652-1658
21. Murakami T, Kawada K, Iwamoto M, Akagami M, Hida K, Nakanishi Y, Kanda K, Kawada M, Seno H, Taketo MM and Sakai Y. The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer 2013; 132: 276-287
22. Utsumi T, Suyama T, Imamura Y, Fuse M, Sakamoto S, Nihei N, Ueda T, Suzuki H, Seki N and Ichikawa T. The Association of CXCR3 and Renal Cell Carcinoma Metastasis. J Urol 2014; 192: 567-574
23. Zamarron BF, Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 2011; 7: 651-658
24. Oldham KA, Parsonage G, Bhatt RI, Wallace DMA, Deshmukh N, Chaudhri S, Adams DH, Lee SP. T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6. Eur Urol 2012; 61: 385-394